DUDLEY LOCAL PHARMACEUTICAL COMMITTEE Chairman: Dan Attry MRPharmS, Pg Dip. 8 Abbotts Mews, Withymoor Village, Brierley Hill, West Midlands, DY5 3DG Tel: 07973632548 E-mail: dan@attry.wanadoo.co.uk Chief Officer: Pete Szczepanski MPharmS, Clin Dip, IP http://psnc.org.uk/dudley-lpc/ 22 Lindford Way, Kings Norton, Birmingham, West Midlands, B38 0BD Tel: 07774719508 E-Mail: petesz1@hotmail.com Minutes of the LPC Committee Meeting on 11 th April 2016 Open Section of the Minutes Present: Pete Sczezpanski (PS), Dan Attry (DA), Stephen Noble (SN), Lynn Rees (LR), Matthew Cox (MC), Scot Taylor (ST), Thomas Thomik (TT), Abul Kashem (AK), Amjid Iqbal (AI), Diane Walker (DW), Vijay Lad (VL) and Mohammed Owaise Kolia (MOK). In attendance: Michelle Dyoss (MD); Dudley CPDO; Lucy Pitt (Pharmacy Show) and Raj Morjaria (PSNC West Midlands Regional Representative). 1. Welcome DA welcomed the members and guests and opened the meeting at 7pm. 2. Apologies MM and JS sent their apologies. 3. Declaration of Interest There were no declarations of interest for this meeting.
4. PHP-P Report MD briefly outlined her report to committee members. HLP/HLO Paid for 30 Health Champions to access online RSPH L2 training through Buttercups. MD commented that if anyone is interested in taking up any of the places to let her know. She has not yet forwarded the details to individual pharmacies as since the move to the CCG she does not have an upto date list of contractors. PS said he would forward this to her. New Framework and prospectus to match national work Claire Walker to support accreditation and reaccreditation complete on Pharmoutcome Questionnaires for Health Champions on Survey Monkey please encourage contractors to complete. MD commented that there have been few responses to date. Producing a database of HCs to record training, comms, etc Services Figures for 2015/16 Alcohol, EHC and Health Checks attached Chlamydia not many kits been given out with EHC. MD emphasised that 2 kits can be given out per EHC; the second for 3 weeks later if negative. Report on Health Checks. There has been an increase in checks via community pharmacy although uptake is still low. Alcohol report. It has been identified that 4 week follow ups are still not being done which could not only create an extra 3 fee for contractors but more patients could potentially be referred into services. Recommendations To go to SMIG Commissioning meeting (Diane McNulty to send Michelle dates) Sent to PHE Other Some of our pharmacy pictures feature in a recent LGA document. David Pitches (Michelle s new line manager) to attend a future LPC meeting. DA or PS to invite to an evening meeting. New budget alignment so no Pharmacy budget as such but access to training budget, comms etc. so money is still available for pharmacy. MD commented that she had spoken to Jag Sangha whom sent his apologies and said there was not much to update. However, they are looking for a community pharmacist volunteer to take part in a short video on the importance of medication for Parkinsons UK. If anyone is interested, please forward details to MD and she will inform JS.
5. Medicines Management/Office of Public Health Report JS sent his apologies to the meeting see section 4. 6. Committee Meetings: a. Area Clinical Effectiveness Committee VL attended the meeting on 24 th March at St James Medical Centre and forwarded his report to committee members prior to the meeting. He covered the main points. FORMULARY SECTION VL commented that there were 3 products of interest with brand optimization which was mainly a cost saving exercise. Levosert new IUD 3 year product cost 66.00 in comparision to Mirena IUD (5 year pdt) 88.00 and Jaydess IUD (3 year pdt). Committee to decide whether to replace Mirena & Jaydess with Levosert? Mirena still more cost effective as it is a 5 year product whereas Levosert currenty only licensed for 3 years although both devices contain exactly the same ingrediants. Committee descision to replace Jaydess with Levosert and leave Mirena on the formulary for patients that require 5 year contraception. Desogestrel Recommended product called Feonella which is cheaper than generic Desogestrel and other branded generics except Cerelle which is already on the formulary. Concerns about supply chains and possible procurement issues whilst trying to source this product as wholesalers may not necessarily stock this item due to insufficient demand? Abasaglar insulin glargine product.- yet another addition to the already extensive range of insulins!. First bio-similar insulin that will provide substantial prescribing costs if the committee approves the switch. Available as a 3ml cartridge and a pre-fill pen. Cost: 35.28/5 compared to 41.50 for Lantus Glargine. Prescribe all insulins by brand name to minimise errors. Descision: Risk assessment needs to be conducted and review in 2 months. Line Extension: Committee approved line extension on Fostair 100/6 for COPD patients and Fostair 200/6 For MDI + DPI, latter in step 4 initiated by a respiratory physician in adult asthma treatment guidelines. Guidelines & Policies. Pharmacy Managed Repeat Guidance was mentioned for ratification. Committee approved. Document on Lifestyle Best Practice Guidelines was discussed with subject of daily alcohol consumption in terms of units for male and female patients. Other lifestyle issues such as
weight management, smoking and physical activity also came into context. Lead author was Liz Corrigan. Descision: Document was approved by the comments. COPD Guidelines: Jo Hamilton Lead practice nurse presentation for the new Asthma Treatment Guidelines asking the committee for its approval. ( See attachment). Quite a useful document with current changes in prescribing for asthma and COPD patients. Prescribe inhalers by brand names to reduce risk of dispensing errors as far as possible except where savings made e.g Sirdupla instead of Seretide. Dermaltology Guidelines : Committee approved in line with dermatologist preferences of emollients. Antimicrobial Guidelines updated and approved by the committee. Clarithromycin added to the formulary for sinusitis and upper respiratory tract infection. C. Diff Guidelines updated Identify and treatment for patients at risk. Medicines & Device Safety : Alert for Sodium Valproate tablets prescribed for women of child bearing age follow up with appropriate advice and effective contraception regime. Wound Sub-group : Wound care guidelines and formulary updated committee ratificationand approvel. AOB: BTI ( Brief Telephone interventions e.g Blood tests for Statins, Flu Vaccine reminders etc to be managed via a call centre? VL commented that the next meeting on 19 th May he is unable to attend but will attend the prescribing subcommittee meeting. b. Prescribing Subcommittee Meeting DP not in attendance to update on the latest meeting. PS to request update at next meeting. c. Primary Care Development Committee TT attended the meeting on 18 th March at Brierley Hill Health and Social Care Centre and forwarded his report to committee members prior to the meeting which can be seen below. The report was merely for information rather than actions needed to be addressed by the committee. In any practice where a CQC inspection raises concerns, the CCG will conduct a support visit within 2 weeks. A follow up visit will be made thereafter. Malling Health is to continue to provide the Excluded Patient Scheme Service on
behalf of the CCG. The service will be provided from the Dudley Urgent Care Centre as from the 1 st of April 2016. The new contractual framework for Primary Medical Services has been finalised and the participation agreement has been drafted. The new contract is to start on the 1 st of April 2016. Dementia indications have remained in the framework. The Dudley CCG diagnosis rate is currently at 58.5% against the national target of 67%. Public Health is supportive of this and has Dementia high on their agenda. Preconditions have been set for surgeries to provide services (face to face appointments with a clinician) every morning and afternoon, Monday to Friday, with no half day closures. The practices are to be open between the core hours of 0800 and 1830, and ensure that telephone access and essential services are available. CQC Inspections a) Bath St Surgery and Waterfront Surgery were found to be inadequate. They are being supported by the CCG with agreed action plans in place. b) Central Clinic's follow up visit was rated at 'GOOD'. The next meeting is on Friday 15 th of April 2016 at BHHSCC at 1pm. 7. A.O.B MC asked if there had been any update with respect to the POD. MD commented she thought it was going ahead. AI commented that DP may have some information from his meeting. PS to follow up with DP for Mays meeting. Lucy Pitt commented about the LPCs attendance at other meetings such as the Primary care development committee. DA commented that this was standard for us and that we try to get a representative from the LPC on all key committees. She also reminded members about attending the Pharmacy Show on 18 th and 19 th October at the NEC. This concludes the minutes from the open section of the meeting. Signed by the Chairman.......................................................... Date: Monday 9 th May 2016